Rheos Baroreflex Hypertension Therapy System to treat resistant hypertension.
Resistant hypertension has a high prevalence and is associated with high morbidity and mortality. The Rheos Baroreflex Hypertension Therapy System is an implantable device that offers a completely new approach to treating patients with resistant hypertension by electrically activating the carotid baroreflex. Preliminary results from current feasibility clinical trials have shown sustained decreases in blood pressure after 1 year. The pivotal trial for US FDA approval and market release is currently ongoing. This article profiles the Rheos System and evaluates the treatment of resistant hypertension in general.
Scheffers
Ingrid J M
IJ
University Hospital Maastricht, Maastricht, The Netherlands. ingrid.scheffers@intmed.unimaas.nl
Kroon
Abraham A
AA
Tordoir
Jan H M
JH
de Leeuw
Peter W
PW
D000818:Animals; D017704:Baroreflex / Q000502:physiology*; D019917:Blood Vessel Prosthesis Implantation / Q000191:economics / Q000295:instrumentation*; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D005240:Feasibility Studies; D006801:Humans; D006973:Hypertension / Q000503:physiopathology* / Q000628:therapy*